Authors: MANEGOLD C DRINGS P PAWINSKI A LENTZ MA VANGLABBEKE M VANZANDWIJK N BACHMANN P SCHNAARS Y SKACEL Z ZATLOUKAL P DOLENSKY J JACKEVICIUS A PETRUZELKA L GIACCONE G

Citation: C. Manegold et al., ORAL IFOSFAMIDE MESNA VERSUS INTRAVENOUS IFOSFAMIDE/MESNA IN NON-SMALL-CELL LUNG-CANCER - A RANDOMIZED PHASE-II TRIAL OF THE EORTC LUNG-CANCER COOPERATIVE GROUP/, Annals of oncology, 7(6), 1996, pp. 637-639

Authors: ROSELL R MOLINA F MORENO I MARTINEZ E PIFARRE A FONT A LI SR SKACEL Z GOMEZCODINA J CAMPS C MONZO M DEANTA JM

Citation: R. Rosell et al., MUTATED K-RAS GENE ANALYSIS IN A RANDOMIZED TRIAL OF PREOPERATIVE CHEMOTHERAPY PLUS SURGERY VERSUS SURGERY IN STAGE IIIA NONSMALL CELL LUNG-CANCER, Lung cancer, 12, 1995, pp. 59-70

Authors: MAREL M MELINOVA L STASTNY B SKACEL Z CERMAK S DEMES R SCHUTZNER J

Citation: M. Marel et al., THE RESULTS OF SURGICAL-TREATMENT OF NONSMALL CELL LUNG-CANCER AT THEPNEUMOLOGICAL-CLINIC IN PRAGUE, CZECH-REPUBLIC, 1985-1990, Lung cancer, 11(3-4), 1994, pp. 293-298

Authors: ROSELL R GOMEZCODINA J CAMPS C MAESTRE J PADILLE J CANTO A MATE JL LI SR ROIG J OLAZABAL A CANELA M ARIZA A SKACEL Z MORERAPRAT J ABAD A

Citation: R. Rosell et al., A RANDOMIZED TRIAL COMPARING PREOPERATIVE CHEMOTHERAPY PLUS SURGERY WITH SURGERY ALONE IN PATIENTS WITH NON-SMALL-CELL LUNG-CANCER, The New England journal of medicine, 330(3), 1994, pp. 153-158

Authors: ROSELL R LI SR SKACEL Z MATE JL MAESTRE J CANELA M TOLOSA E ARMENGOL P BARNADAS A ARIZA A

Citation: R. Rosell et al., PROGNOSTIC IMPACT OF MUTATED K-RAS GENE IN SURGICALLY RESECTED NONSMALL CELL LUNG-CANCER PATIENTS, Oncogene, 8(9), 1993, pp. 2407-2412